William R. Huckle, Editor
|
Boston, MA
Postponed until Summer 2021
|
Help support our trainee scholarships
Any profits from the sale of these NAVBO items will help fund additional scholarships for students in the Advancing Young Voices Through Diversity and Inclusion Program. Thank you for your support!
Double layered mask
Coffee mug featuring the NAVBO Online logo
Canvas tote
Fanny pack
Fun NAVBO sticker!
|
Shop at Amazon?
Help Support NAVBO
|
Vascular Biology Publications Alert Now Available by Subscription The NAVBO Vascular Biology Publications Alert will now be available to non-members for a $55 a year subscription. If you would like to receive this alert, but are not a member, please contact Danielle at membership@navbo.org.
|
Partner Network Advantage on the NAVBO Job Board
|
Why post your job on NAVBO's career center rather than going directly to the larger job networks?
Pricing on the mass job boards can vary, but to get a job noticed you typically have to sponsor it for $5 - $10 per day, which can add up quickly especially since you also pay for each click the job gets. When you add it all together, you could be spending up to $45 per day on your job posting. But, when posting a job on NAVBO's career center, you simply pay a flat fee! The Premium package includes our Exclusive Extended Partner Network - which means the jobs are broadcast to sites like ZipRecruiter and Jobs2Careers and more for a flat fee.
With special member pricing, you can post a job for as low as $300 with this Partner Network. You never pay for each click, just the flat fee on the NAVBO career center. In addition, the Premium package includes a 60-day job posting making it a great value. The Premium packages also offer features like having your company's logo featured on the career center homepage, having your job appear first in search results, and more.
|
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes. Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25,2018. The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to change your communication preferences.
Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
|
|
|
|
|
Journal Club
Plan to join us today, November 19 at 1:00pmEST for the Journal Club as we discuss the following paper:
Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, Terry M, Jacobson CA, Wrijil L, Ducat S, Brook OR, Miller AD, Porto M, Pellegrini KL, Pino M, Hoang TN, Chandrashekar A, Patel S, Stephenson K, Bosinger SE, Andersen H, Lewis MG, Hecht JL, Sorger PK, Martinot AJ, Estes JD, Barouch DH. Cell. 2020 Oct 9:S0092-8674(20)31311-8.
William Hughes, Medical College of Wisconsin, will present this paper.
Journal Club participation is limited to current NAVBO members.
Seeking volunteers!
Would you like to present a Journal Club?
We are looking for NAVBO members who are postdoctoral fellows or faculty to give a review of an exciting recent paper (should be within two months of publication).
Presentations are 30 minutes in duration, followed by a 30-minute open discussion.
Contact Anita Pustelnik, NAVBO Education Coordinator, anita@navbo.org, if interested.
Our next webinar on December 3 at 1:00pmEST will feature Luisa Iruela-Arispe of Northwestern University. Her presentation is titled " Reflecting on the power of cell-cell interactions with a Notch-centric focus."
For more details and to register, go to:
We then look forward to starting the New Year with a webinar by Jason Fish of the University of Toronto on January 7, 2021. Dr. Fish's presentation is titled, "Somatic oncogenic mutations in the endothelium drive vascular malformations."
Great opportunities continue with a webinar by Karen Hirschi, University of Virginia. Her presentation, titled "Regulation of Endothelial Cell Specialization" will take place on
February 18, 2021.
|
The Lab of Dr. Teresa Sanchez
|
Vascular Biology 2020 - Recordings Available
|
You can still register and gain access to the recordings!
There are 77 presentations (45 by invited speakers and 32 short talks from selected abstract presenters). Plus - you'll also gain access to almost 200 ePosters and the recordings of several professional development related round tables.
If you spoke to colleagues that attended, then you've heard it was a great meeting - you don't have to miss it entirely!
We've extended the availability of the recordings to November 30!
(In fairness to those who registered and attended the meeting, the same registration fees remain in effect - $175 for regular members; $125 for trainee members and $325 for non-members) |
Lessons Learned (from the November 5 issue)
|
Teresa Sanchez
My name is Teresa Sanchez and I am an Assistant Professor of Pathology and Laboratory Medicine, with a secondary appointment at the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. I obtained my first independent position and established my laboratory initially at Beth Israel Deaconess Medical Center, Harvard Medical School. Subsequently, for family reasons, I had to relocate to New York City, and I moved my laboratory to Weill Cornell Medicine. I am very privileged to have had the opportunity to establish my research program in two outstanding institutions and I am happy to share my experience transitioning from trainee to faculty, setting up my lab and moving my research program from Harvard Medical School to Weill Cornell Medicine.
Dr. Sanchez shares advice on transitioning from trainee to independent investigator, building a team, balancing personal life and work, moving the laboratory and more. Read Dr. Sanchez's full article on our website.
You can view all of the Lessons Learned by visiting our web site. Go to
|
Spotlight on Trainees (from our November 5 issue)
|
Round Table at VB2020 Mulls Training Challenges in the COVID-19 Era
A panel discussion at last week's VB2020, featuring training program leaders Brian Black (UCSF), Kishore Wary (UI-Chicago) and Michael Chin (Tufts), as well as PhD student Katrina Colucci-Chang (Virginia Tech), examined a variety of impacts the coronavirus pandemic has had on the training experience in cardiovascular biology. The conversation, moderated by Bill Huckle from Virginia Tech, covered such topics as institutional and personal resilience, interruptions to funding and progress to degree, and the unexpected positives that have emerged as we have learned to cope with our challenging circumstances. Attendees and panelists agreed that, although extramural sponsors have shown extraordinary flexibility for deadlines, progress reports, and more, the times are proving uniquely stressful, emphasizing the importance of attention to mental health needs. The effects of social isolation, particularly among international students, also were of concern. The session ended on an upbeat note, however, as trainees and mentors alike shared appreciation for their colleagues' gestures of humanity, willingness to adapt cheerfully, and focus on our common goals. Quoting from the Zoom chat: "The pandemic is teaching us to be smarter, more organized, focused scientists" and "as a trainee I have learned to multi-task, organizing my agenda and meeting my deadlines! Silver lining!!"
If you'd like to watch the video of this round table discussion, follow this link:
|
Welcome to our New Members:
Gabriela D'Amico, University College London
Isabella Grumbach, University of Iowa
Minah Kim, Columbia University
|
Harvard Medical School Seminars in Vascular Biology
Organized by several NAVBO members (Peter Libby, Michael Gimbrone, Masanori Aikawa, Guillermo Garcia-Cardena, and Patricia D'Amore), this seminar series offers weekly talks on Thursdays at 4:30 PM (ET). Here's what's coming up:
November 19
Robert Padera, MD, PhD
Harvard Medical School
"Autopsy Pathology of COVID-19: A First-Person Perspective"
December 3
University of Virginia Health System
"B Lymphocyte-Mediated Protective Immunity in Atherosclerosis"
UC San Diego School of Medicine
"The Oxidation Hypothesis of Atherosclerosis Revisited: A Pivotal Role of OxPL in Atherosclerosis, NASH and Inflammation"
December 17
Catherine "Lynn" Hedrick, PhD
La Jolla Institute for Immunology
Talk Title Pending
|
Recent Publications by NAVBO Members |
Marcksl1 modulates endothelial cell mechanoresponse to haemodynamic forces to control blood vessel shape and size
Nature Communications
The formation of vascular tubes is driven by extensive changes in endothelial cell (EC) shape. Here, we have identified a role of the actin-binding protein, Marcksl1, in modulating the mechanical properties of EC cortex to regulate cell shape and vessel structure during angiogenesis. Increasing and depleting Marcksl1 expression level in vivo results in an increase and decrease, respectively, in EC size and the diameter of microvessels. Read more
Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
Critical Care Explorations
Objectives: Coronavirus disease 2019 continues to spread rapidly with high mortality. We performed metabolomics profiling of critically ill coronavirus disease 2019 patients to understand better the underlying pathologic processes and pathways, and to identify potential diagnostic/prognostic biomarkers. Read more
"Then and Now," Mapping the 25 Year Evolution and Impact of North American Vascular Biology Organization Science Through Publications of its Founding and Current Members
Frontiers in Research Metrics and Analytics
Scholarly organizations bring together experts to move forward specific areas of scientific endeavor. More than 5,000 scholarly societies exist world-wide yet little is known about the composition, evolution, and collaboration of experts within these organizations. Read more
VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration
Circulation
Background: Recent discoveries have indicated that, in the developing heart, sinus venosus and endocardium provide major sources of endothelium for coronary vessel growth that supports the expanding myocardium. Read more
|
Industry News (from our November 5 issue)
|
Whither science in the election's aftermath?
As the US (and much of the world) watches the slow unfolding of the post-election process, we have extra time to ponder the ramifications of a Biden or Trump victory on the prospects of federal support for basic and applied research. Elizabeth Redden, writing in Inside Higher Ed, notes that this has been far from a typical election year, when the candidates' differences typically have not strayed beyond subtleties of their respective priorities for NIH or NSF funding. Moreover, Redden notes soberly that a more fundamental issue was effectively on the ballot in this election: the respect for science expected to be shown by key decision-makers in government. The incumbent has continually downplayed the risks of the pandemic and the need for public health measures. Candidate Biden has shown more willingness to take seriously the threats posed by the coronavirus as well as climate change and other environmental challenges. Regardless of the outcome of the election, it will likely take years to restore science to a proudly featured, and publicly admired, role in our President's portfolio.
|
Frontiers in Cardiovascular Medicine
Special Research Topics
What do we know about COVID-19 implications for cardiovascular disease?
The coronavirus epidemic causes major cardiovascular complications. Underlying mechanisms, however, remain incompletely understood. Frontiers in Cardiovascular Medicine invite you to submit your article on this topic. We consider all types of manuscripts: fundamental basic science reports, translational or clinical studies, review articles and methodology papers.
We have already published 17 articles. More submissions are currently under review. Due to the popularity and the emerging nature of this topic, we decided to extend the deadline to December 31, 2020. All articles submitted before this deadline will be published free of charge. We encourage you to take advantage of this opportunity to publish your original study or review article in FCVM (Impact Factor 3.915).
|
Dear friends and colleagues,
Jun Zhang, PhD (Associate Professor, Texas Tech University Health Sciences Center El Paso), is organizing a special issue entitled "Advancements in Cerebral Cavernous Malformations" in journal Vessel Plus (VP, ISSN 2574-1209).
This special issue aims to bring readers the up-to-date view of advancements in the scientific and technology innovations, translational and basic-science studies, and clinical trials of cerebral cavernous malformations. For more details about this special issue and the "Author Instructions", please visit the website at https://vpjournal.net/journal/special_detail/459.
Are you interested in contributing an article before February 15, 2021? If yes, please contact Jun Zhang (jun.zhang2000@gmail.com), the Guest Editor for this special issue, or Mavis Wei (mavis@vpjournal.net), the Managing Editor of VP. If you need additional information, please feel free to contact us.
VP is an online open access journal which was launched on March 31, 2017 by OAE Publishing Inc. It waives the Article Processing Charge (APC) for all publications since launched. Thus, your manuscripts will be published totally free of charge once officially accepted after quick and rigorous peer-review. Meanwhile, all manuscripts published in VP will be immediately available online for free downloading and reading. Further, if the work is funded by NIH, we can deposit it in PubMed on your behalf.
Thank you for considering this invitation.
|
Dear friends and colleagues,
This special issue aims to provide readers with an up-to-date advancement in lesser-known genes, proteins and signaling pathways in vascular biology. Manuscripts related to concepts from these genes and proteins and their associated signaling pathways that connect into the well-established vascular ligand-receptor signaling systems are welcome. For more details about this special issue and the "Author Instructions", please visit the website at https://vpjournal.net/journal/special_detail/478. Are you interested in contributing an article before December 31, 2020? If yes, please contact Ramani Ramchandran (rramchan@mcw.edu), the Guest Editor for this special issue, or Mavis Wei (mavis@vpjournal.net), the Managing Editor of VP. If you need additional information, please feel free to contact us. VP is an online open access journal which was launched on March 31, 2017 by OAE Publishing Inc. It waives the Article Processing Charge (APC) for all publications since launched. Thus, your manuscripts will be published totally free of charge once officially accepted after quick and rigorous peer-review. Meanwhile, all manuscripts published in VP will be immediately available online for free downloading and reading. Further, if the work is funded by NIH, we can deposit it in PubMed on your behalf. Thank you for considering this invitation.
|
|
|